ATLAS fair value
ATLAS has no fair value for this stock today.
Outset Medical stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
46%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Outset Medical a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $3.69 and $4.89; in 9 out of 10, between $2.87 and $6.28. Estimated annual volatility is 81%.
ATLAS does not publish a fair value for OM right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks OM has traded between $2.84 and $14.49. Today it is 70.1% below that high and 53% above its low.
On the business: revenue grew 5.1% year over year; net margin is 68.3%.
Its beta is 1.90: it tends to move more than the market, both up and down.
Outset Medical, Inc. is a medical technology company focused on dialysis care. Its core product, the Tablo Hemodialysis System, is designed to simplify hemodialysis by combining integrated water purification, on-demand dialysate production, software, and connectivity in a compact platform.
Want to see everything about Outset Medical?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Outset Medical, Inc. is a medical technology company focused on dialysis care. Its core product, the Tablo Hemodialysis System, is designed to simplify hemodialysis by combining integrated water purification, on-demand dialysate production, software, and connectivity in a compact platform.
46%: close to a coin flip. In half of the simulated outcomes, OM ends the month between $3.69 and $4.89.
Outset Medical's market capitalization is $74.4M. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 81%. In a typical month, half of the outcomes end between $3.69 and $4.89.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy